Literature DB >> 19900109

Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand.

Sushil Pandey1, Sandie Newton, Arlo Upton, Sally Roberts, Dragana Drinković.   

Abstract

AIMS: To describe the molecular basis of pyrazinamide (PZA) resistance among Mycobacterium tuberculosis in New Zealand, and to compare the pncA gene sequence among isolates with phenotypic (Bactec 960 and Wayne's assay) evidence of PZA resistance.
METHODS: The pncA gene of 26 clinical isolates of M. tuberculosis found to be PZA resistant by phenotypic methods was sequenced. Phenotypic and genotypic data were compared.
RESULTS: Mutations were detected in 11 isolates, predominantely among isolates with a multi-drug resistance phenotype. While the mutations were dispersed along the pncA gene, a clustering of mutations were found at amino acid Ser18-His57 and His82-Val128 regions. Seven of the identified mutations have not been described previously.
CONCLUSIONS: A high diversity of pncA gene mutation was seen among PZA resistant strains of M. tuberculosis. The Bactec 960 phenotypic test may over report PZA resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19900109     DOI: 10.1080/00313020903071587

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  14 in total

1.  Kinetics and inhibition of nicotinamidase from Mycobacterium tuberculosis.

Authors:  Derrick R Seiner; Subray S Hegde; John S Blanchard
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.

Authors:  Farahnoosh Doustdar; Mohammad Pazhang; Faramarz Mehrnejad; Mehrnoosh Safarzadeh; Davod Rabiei; Nader Chaparzadeh; Hanieh Falahati; Mohammad Mir-Derikvand
Journal:  Protein J       Date:  2015-06       Impact factor: 2.371

3.  Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance.

Authors:  Alessandro Mustazzolu; Angelo Iacobino; Federico Giannoni; Claudio Piersimoni; Lanfranco Fattorini
Journal:  J Clin Microbiol       Date:  2017-09-13       Impact factor: 5.948

Review 4.  Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.

Authors:  Kwok Chiu Chang; Wing Wai Yew; Ying Zhang
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

Review 5.  Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.

Authors:  Sarah M Ramirez-Busby; Faramarz Valafar
Journal:  Antimicrob Agents Chemother       Date:  2015-06-15       Impact factor: 5.191

6.  Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide.

Authors:  Sami O Simons; Jakko van Ingen; Tridia van der Laan; Arnout Mulder; P N Richard Dekhuijzen; Martin J Boeree; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2011-11-16       Impact factor: 5.948

Review 7.  Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update.

Authors:  Ananthi Rajendran; Kannan Palaniyandi
Journal:  Curr Microbiol       Date:  2022-10-08       Impact factor: 2.343

8.  Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum.

Authors:  Claudio Piersimoni; Alessandro Mustazzolu; Federico Giannoni; Stefano Bornigia; Giancarlo Gherardi; Lanfranco Fattorini
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

9.  Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis.

Authors:  Miguel Quiliano; Andres Hazaet Gutierrez; Robert Hugh Gilman; César López; Wilfredo Evangelista; Jun Sotelo; Patricia Sheen; Mirko Zimic
Journal:  Bioinformation       Date:  2011-07-19

10.  Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.

Authors:  Stéphanie Petrella; Nathalie Gelus-Ziental; Arnaud Maudry; Caroline Laurans; Rachid Boudjelloul; Wladimir Sougakoff
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.